Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

The 2025 "American Idol" champion stops by "GMA" to perform his new single, “Heal,” and reflect on his path to victory. A new Trump administration vaccine policy will limit access to COVID-19 shots.

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...